Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Allstate Corp (ALL) Price & Performance

AbCellera Biologics IncTrade
Allstate CorpTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Allstate Corp — how do they compare? AbCellera Biologics Inc trades at $8.98 (market cap $2.99B), while Allstate Corp trades at $262 (market cap $66.31B). The key difference: Allstate Corp is far larger — about 22.2× AbCellera Biologics Inc's market cap, and Allstate Corp pays a 1.65% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLALL
Market Cap
$2.99B$66.31B
Sector
HealthFinancials
52-Week High
$9.76$275.11
52-Week Low
$2.78$190.00
Enterprise Value
$2.58B$74.96B
Dividend Yield
1.65%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Allstate Corp

On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.

Read more on ALL